Skip to main content
Clinical Trials/ISRCTN40496794
ISRCTN40496794
Completed
N/A

A human dietary intervention study to investigate the effect of sulforaphane on prostate cancer interception

Quadram Institute Bioscience0 sites49 target enrollmentOctober 11, 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Quadram Institute Bioscience
Enrollment
49
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30982861 (added 13/08/2019)

Registry
who.int
Start Date
October 11, 2013
End Date
October 31, 2017
Last Updated
4 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 2\. Diagnosed with low and intermediate prostate cancer on active surveillance
  • 3\. Aged 18\-80 years
  • 4\. Body mass index (BMI) between 19\.5 and 35 kg/m2
  • 5\. Smokers and non\-smokers

Exclusion Criteria

  • 1\. Those undergoing chemopreventive therapy
  • 2\. Those regularly taking 5a\-reductase inhibitors or testosterone replacement medicines
  • 3\. Those on warfarin treatment
  • 4\. Those diagnosed with diabetes
  • 5\. Those diagnosed with or suspected to be high\-risk for HIV and/or hepatitis
  • 6\. Those allergic to any of the ingredients of the broccoli soups
  • 7\. Those taking dietary supplements or herbal remedies which may affect the study outcome unless the volunteer is willing to discontinue taking them for 1 month prior to starting study. Please note that some supplements may not affect the study and this will be assessed on an individual basis
  • 8\. Parallel participation in another research project which involves dietary intervention
  • 9\. Any person related to or living with any member of the study team

Outcomes

Primary Outcomes

Not specified

Similar Trials